Domov › Množni mielom › Distrikta Columbia › Washington
Klinične študije za Množni mielom v Washington, DC
22 študij za Množni mielom išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Vključevanje udeležencevFaza 3
- Research Site, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Tissue Collection for Studies of Lymph Cancer
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Vključevanje udeležencevFaza 4
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Vključevanje udeležencevFaza 3
- Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
18F-Fluciclovine PET/CT in Multiple Myeloma
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Vključevanje udeležencevFaza 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Vključevanje udeležencevFaza 2
- Lombardi Comprehensive Cancer Center, Washington D.C.
Collection of Tissue Samples for Cancer Research
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Vključevanje udeležencevFaza 3
- Georgetown University Medical Center, Washington D.C.
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Vključevanje udeležencevFaza 3
- MedStar Washington Hospital Center MedStar Georgetown Cancer Institute, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Vključevanje udeležencevFaza 2
- GSK Investigational Site, Bethesda · 7 mi stran
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Vključevanje udeležencev
- Georgetown University School of Medicine, Washington D.C.
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Vključevanje udeležencevFaza 1
- Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · 7 mi stran
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Vključevanje udeležencevFaza 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi stran
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Vključevanje udeležencevFaza 3
- Sibley Memorial Hospital, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Vključevanje udeležencevFaza 3
- GSK Investigational Site, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Vključevanje udeležencevFaza 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Študije za Množni mielom v drugih mestih
- New York City, NY60 študij
- Boston, MA42 študij
- Atlanta, GA42 študij
- Houston, TX38 študij
- Durham, NC37 študij
- Nashville, TN32 študij
- Denver, CO27 študij
- Rochester, MN24 študij
- St. Louis, MO24 študij
- Columbus, OH24 študij
- Baldwin Park, CA23 študij
- Edison, NJ22 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak55 študij
- Rak dojke46 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Akutna mieločna levkemija24 študij
- Rak jajčnikov23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.